These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8630682)

  • 1. A phase I pilot study of BCNU plus thymidine in patients with refractory cancer.
    Schultz MZ; Sandler AB; Durivage HJ; Cooper DL
    Cancer Invest; 1996; 14(3):218-24. PubMed ID: 8630682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Cooper DL; Prusoff WH
    Cancer Res; 1991 Mar; 51(6):1586-90. PubMed ID: 1900213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study.
    Adams DM; Zhou T; Berg SL; Bernstein M; Neville K; Blaney SM;
    Pediatr Blood Cancer; 2008 Mar; 50(3):549-53. PubMed ID: 17941066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of thymidine (dThd) and cisplatin (DDP) given in combination.
    Chiuten DF; Valdivieso M; Benvenuto JA; Drewinko B; Bedikian A; Bodey GP
    Am J Clin Oncol; 1986 Apr; 9(2):129-31. PubMed ID: 3717079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV; Buckner JC; Schomberg PJ; Pitot HC; Ingle JN; Cascino TL
    Neurosurgery; 1999 Jan; 44(1):67-73. PubMed ID: 9894965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
    Papadopoulos KP; Balmaceda C; Fetell M; Kaufman E; Vahdat LT; Bruce J; Sisti M; Isaacson S; De LaPaz R; Savage DG; Troxel A; Antman KH; Hesdorffer CS
    J Neurooncol; 1999 Sep; 44(2):155-62. PubMed ID: 10619499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.
    Schold SC; Kuhn JG; Chang SM; Bosik ME; Robins HI; Mehta MP; Spence AM; Fulton D; Fink KL; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):34-9. PubMed ID: 11302252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Prusoff WH
    Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ; Malkin MG; Kleber M; Abrey LE
    Neuro Oncol; 2004 Jul; 6(3):247-52. PubMed ID: 15279717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer.
    Micetich KC; Futscher B; Koch D; Fisher RI; Erickson LC
    J Natl Cancer Inst; 1992 Feb; 84(4):256-60. PubMed ID: 1531148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV; Buckner JC; Schomberg PJ; Cascino TL; Burch PA; Dinapoli RP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):297-302. PubMed ID: 9457812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
    Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
    Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential therapy with dacarbazine and carmustine: a phase I study.
    Mitchell RB; Dolan ME; Janisch L; Vogelzang NJ; Ratain MJ; Schilsky RL
    Cancer Chemother Pharmacol; 1994; 34(6):509-14. PubMed ID: 7923562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
    Schilsky RL; O'Laughlin K; Ratain MJ
    Cancer Res; 1986 Aug; 46(8):4184-8. PubMed ID: 3731086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion.
    Chiuten DF; Wiernik PH; Zaharko DS; Edwards L
    Cancer Res; 1980 Mar; 40(3):818-22. PubMed ID: 7471098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation and enhancement of antitumor activity by co-administration of 1,3-bis(2-chloroethyl)-1-nitrosourea and thymidine.
    Poo WJ; Guo X; Haslund B; Mozdziesz DE
    Biochem Pharmacol; 1997 Mar; 53(5):705-13. PubMed ID: 9113090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.